Learn more about business developments in Europe

Press releases

New belief-based Patient Support Programme (PSP) Launched for People with Relapsing Multiple Sclerosis

Press Releases | 19 Oct

Amsterdam, 19 October 2017: People living with relapsing forms of Multiple Sclerosis (MS) can now ac...

Read more

Teva Announces tomy’s Award Winner at Oncology Satellite Symposium during the 7th International Symposium on Acute Promyelocytic Leukemia (APL)

Press Releases | 27 Sep

Best oral presenter Dr. Olga Salamero chosen as the tomy’s winner. Research focused on treatments in...

Read more

Teva Presents First Real-World Evidence Demonstrating Treatment with DuoResp Spiromax® Inhaler was Comparable to Symbicort Turbuhaler®

Press Releases | 12 Sep

Teva Presents First Real-World Evidence Demonstrating Treatment with DuoResp Spiromax® Inhaler was C...

Read more

Carers In The UK ‘Just About Managing’: Growing Number Of Inexperienced Caregivers Search Online For Support And Trustworthy Information

Press Releases | 11 Sep

Global survey of 3,086 carers finds 57% of UK caregivers seek out advice and information online, how...

Read more

Teva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) International Congress

Press Releases | 07 Sep

Teva To Present New Asthma and COPD Data at the 2017 European Respiratory Society (ERS) Internationa...

Read more

Teva Team Scales Heights of France’s Mount Ventoux to raise awareness for Multiple Sclerosis

Press Releases | 06 Jun

Teva partners with charity ‘Climbing Against MS’ for 7th annual ascent up Mont Ventoux – helping rai...

Read more

Teva Launches Innovative Multiple Sclerosis (MS) Social Media Campaign to Mark World MS Day

Press Releases | 22 May

In support of World MS Day’s official #LifewithMS theme, Teva launches social media campaign to rais...

Read more

Cancer pain specialists debate latest approaches in breakthrough cancer pain (BTcP) management

Press Releases | 15 May

June 16 webcast brings together oncologists, pain specialists, nurses and patient representatives to...

Read more

Teva Launches Innovative Social Media Campaign on Optimal Inhaler Use for World Asthma Day

Press Releases | 24 Apr

The ‘Get it Right’ Campaign Calls for Increased Awareness and Dialogue on Correct Asthma Inhaler Tec...

Read more

Breaking bad: Oncologists would welcome more training in giving bad news

Press Releases | 11 Apr

At the third annual pan-European BeCOn Summit, oncologists support more formal training in how to ho...

Read more

New European data shows men today are ‘in sync’ when asked about partner’s menstrual cycle

Press Releases | 06 Apr

Findings presented as Teva launches ‘It’s About Time’ women’s health portal offering information on ...

Read more

Women report higher satisfaction with contraception which extends time between periods, Teva study finds

Press Releases | 23 Mar

March 20, 2017 – Teva Pharmaceutical Europe today announced new data, which shows women using extend...

Read more

Teva announces appointment of New President & CEO, Teva Generics Europe

Press Releases | 13 Dec

Richard Daniell to assume position of President & CEO, Teva Generics Europe, and succeeds Dipankar B...

Read more

Young adults in Europe shun established health websites for health stories on unvetted, forum-style websites survey reveals

Press Releases | 08 Sep

Survey of 5,000 adults in Europe shows  Millennials take comfort in hearing about people’s similar h...

Read more

Women with breast cancer and men with prostate cancer talk differently online about cancer – social listening research shows

Press Releases | 22 Feb

Research identified over 20,000 online cancer conversations over the past 3 yearsAnalysis shows pros...

Read more
Learn more about

Teva in Europe

With patients across Europe playing a growing role in managing their own health, partnering with patients and carers is at the heart of Teva’s strategy to innovate beyond the pill.

Teva is one of the world’s top 15 pharmaceutical companies, dispensing 1.2 billion packs of medication in Europe per year. In addition to being Europe’s largest generic medicines manufacturer, Teva is a leader in innovative, specialty medicines for disorders of the central nervous system and for respiratory diseases, cancer and women’s health. Our R&D capabilities are unique in the industry – spanning proprietary medicines, innovation around existing molecules, as well as generic and over-the-counter treatments.

With patients across Europe playing a growing role in managing their own health, partnering with patients and carers is at the heart of Teva’s strategy to innovate beyond the pill. We are increasingly combining our drug development capabilities with devices, services and digital technologies that are helping to shape the future of personalised medicine - supporting patients’ needs and improving healthcare outcomes

Teva Europe Fast Facts & Media FAQs

Did you know?